FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,053 | -58.6% | 1,440 | -7.0% | 0.00% | – |
Q2 2023 | $7,373 | +23683.9% | 1,549 | -71.9% | 0.00% | – |
Q1 2023 | $31 | +933.3% | 5,505 | +1735.0% | 0.00% | – |
Q4 2022 | $3 | -100.0% | 300 | -87.8% | 0.00% | – |
Q3 2022 | $51,000 | -1.9% | 2,462 | +17.2% | 0.00% | – |
Q2 2022 | $52,000 | -42.9% | 2,100 | -11.0% | 0.00% | -100.0% |
Q1 2022 | $91,000 | -13.3% | 2,360 | -7.1% | 0.00% | 0.0% |
Q4 2021 | $105,000 | -39.0% | 2,540 | -12.4% | 0.00% | 0.0% |
Q3 2021 | $172,000 | -36.1% | 2,900 | -6.5% | 0.00% | -50.0% |
Q2 2021 | $269,000 | -7.6% | 3,100 | -12.2% | 0.00% | 0.0% |
Q1 2021 | $291,000 | -18.5% | 3,530 | -10.2% | 0.00% | 0.0% |
Q4 2020 | $357,000 | +264.3% | 3,930 | +60.1% | 0.00% | +100.0% |
Q3 2020 | $98,000 | +415.8% | 2,455 | +342.3% | 0.00% | – |
Q2 2020 | $19,000 | +58.3% | 555 | +5.7% | 0.00% | – |
Q1 2020 | $12,000 | 0.0% | 525 | -12.5% | 0.00% | – |
Q4 2019 | $12,000 | +33.3% | 600 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | 0.0% | 600 | +39.5% | 0.00% | – |
Q2 2019 | $9,000 | +12.5% | 430 | 0.0% | 0.00% | – |
Q1 2019 | $8,000 | +33.3% | 430 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | -14.3% | 430 | 0.0% | 0.00% | – |
Q3 2018 | $7,000 | – | 430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |